Substance P promotes sleep in the ventrolateral preoptic area of rats.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Brain Research

• Publication date

  2004-12-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BRAINRES.2004.09.017PMID 15527748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain

  2003cited by this paper
• Substance P in the descending cholinergic projection to REM sleep‐induction regions of the rat pontine reticular formation: anatomical and electrophysiological analyses

  2002cited by this paper
• Afferents to the Ventrolateral Preoptic Nucleus

  2002cited by this paper
• Effects of the Neuropeptide Substance P on Sleep, Mood, and Neuroendocrine Measures in Healthy Young Men

  2002cited by this paper
• Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species.

  2002cited by this paper
• Modulation of serotonergic projection from dorsal raphe nucleus to basolateral amygdala on sleep-waking cycle of rats.

  2002cited by this paper
• Co-localization of NK1-receptor mRNA with glutamate immunopositivity in cat hypothalamic neurons by the combination of in situ hybridization and immunohistochemistry

  2001cited by this paper
• Co-localization of NK(1)-receptor mRNA with glutamate immunopositivity in cat hypothalamic neurons by the combination of in situ hybridization and immunohistochemistry.

  2001cited by this paper
• The sleep switch: hypothalamic control of sleep and wakefulness.

  2001cited by this paper
• Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor

  2001cited by this paper
• Blockade of NK-1 receptors in the lateral commissural nucleus tractus solitarii of awake rats had no effect on the cardiovascular responses to chemoreflex activation.

  2000cited by this paper
• Role and Origin of the GABAergic Innervation of Dorsal Raphe Serotonergic Neurons

  2000cited by this paper
• Effect of Lesions of the Ventrolateral Preoptic Nucleus on NREM and REM Sleep

  2000cited by this paper
• Substance P Is Involved in Terminating the Hypothalamo-Pituitary-Adrenal Axis Response to Acute Stress Through Centrally Located Neurokinin-1 Receptors

  2000cited by this paper
• Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats.

  1998cited by this paper
• Effect of NMDA lesion of the medial preoptic neurons on sleep and other functions.

  1998cited by this paper
• Recovery of sleep after fetal preoptic transplantation in medial preoptic area-lesioned rats.

  1998cited by this paper
• GABA release in the locus coeruleus as a function of sleep/wake state.

  1997cited by this paper
• Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain

  1997cited by this paper
• Electrophysiology of excitatory and inhibitory afferents to rat histaminergic tuberomammillary nucleus neurons from hypothalamic and forebrain sites.

  1997cited by this paper
• GABA release in posterior hypothalamus across sleep-wake cycle.

  1996cited by this paper
• Activation of Ventrolateral Preoptic Neurons During Sleep

  1996cited by this paper
• Neuronal discharge of preoptic/anterior hypothalamic thermosensitive neurons: relation to NREM sleep.

  1995cited by this paper
• Effects of the phospholipase-C inhibitor, U73122, on signaling and secretion in pituitary gonadotrophs.

  1995cited by this paper
• Changes in sleep-wakefulness after kainic acid lesion of the preoptic area in rats.

  1994cited by this paper
• Projections of GABAergic and cholinergic basal forebrain and GABAergic preoptic‐anterior hypothalamic neurons to the posterior lateral hypothalamus of the rat

  1994cited by this paper
• Distribution of the substance P receptor (NK-1 receptor) in the central nervous system.

  1993cited by this paper
• Molecular cloning, structural characterization and functional expression of the human substance P receptor.

  1991cited by this paper
• Distribution of substance P, GnRH, Met-enkephalin in the central nervous system of the pig.

  1991cited by this paper
• Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat.

  1989cited by this paper
• Sleep suppression following kainic acid-induced lesions of the basal forebrain.

  1986cited by this paper
• Preoptic area unit activity during sleep and wakefulness in the cat.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• [Substance P - a neuropeptide transmitter].

  1982influential reference
• Substance P.

  1982influential reference
• 3-mercaptopropionic acid inhibits GABA release from rat brain slices in vitro.

  1981cited by this paper
• [Effect of a substance P analog on sleep deprivation].

  1980cited by this paper
• The effect of 3-mercaptopropionate, an inhibitor of glutamate decarboxylase, on the levels of GABA and other amino acids, and on presynaptic inhibition in the rat cuneate nucleus.

  1978cited by this paper
• Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain.

  1974cited by this paper
• SLEEP AS A PROBLEM OF LOCALIZATION

  1930cited by this paper

• Abdominal massage modulates gut microbiota and brain-gut peptides in insomnia model rats

  2025cites this paper
• Mediation Effect of CSF Substance P on the Association Between Smoking and Sleep

  2025cites this paper
• Roles of Neuropeptides in Sleep–Wake Regulation

  2022cites this paper
• Short-term maintenance on a high-sucrose diet alleviates aging-induced sleep fragmentation in drosophila

  2021cites this paper
• Endocrinology of sleep

  2021cites this paper
• Fibromyalgia Syndrome and Sleep

  2021cites this paper
• Activation of Preoptic Tachykinin 1 Neurons Promotes Wakefulness over Sleep and Volatile Anesthetic-Induced Unconsciousness.

  2020cites this paper
• Sleep State Dependence of Optogenetically evoked Responses in Neuronal Nitric Oxide Synthase-positive Cells of the Cerebral Cortex.

  2018cites this paper
• The potential role of substance P in brainstem homeostatic control in the pathogenesis of sudden infant death syndrome (SIDS).

  2018cites this paper
• Sleep-inducing effect of substance P-cholera toxin A subunit in mice.

  2017cites this paper
• Identification of Preoptic Sleep Neurons Using Retrograde Labeling and Gene Profiling

  2017cites this paper
• Activation of α1 adrenoceptors in ventrolateral orbital cortex attenuates allodynia induced by spared nerve injury in rats.

  2016influential citation
• N‐acetyl‐l‐tryptophan, but not N‐acetyl‐d‐tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis

  2015cites this paper
• Neuropeptidergic control of sleep and wakefulness.

  2014cites this paper
• Sensitivity to self-administered cocaine within the lateral preoptic–rostral lateral hypothalamic continuum

  2014cites this paper
• Microinjection of Adenosine into the Hypothalamic Ventrolateral Preoptic Area Enhances Wakefulness via the A1 Receptor in Rats

  2013cites this paper
• Cortical nNOS neurons co-express the NK1 receptor and are depolarized by Substance P in multiple mammalian species

  2012cites this paper
• Winning a Won Game: Caffeine Panacea for Obesity Syndemic

  2010cites this paper
• A Neurochemical Perspective on States of Consciousness

  2009cites this paper
• The paradox of caffeine-zolpidem interaction: a network analysis.

  2009cites this paper
• Rodent models of insomnia: a review of experimental procedures that induce sleep disturbances.

  2009cites this paper
• Electroacupuncture treatment of chronic insomniacs.

  2009cites this paper
• Upregulating substance P levels to treat obstructive sleep apnea

  2008cites this paper
• Upregulating substance P levels to treat obstructive sleep apnea.

  2008cites this paper
• Relationship between serum substance P levels and daytime sleepiness in obstructive sleep apnea syndrome.

  2007cites this paper
• Participation of muscarinic and nicotinic cholinoreceptors of hypothalamic preoptic area in control of thermoregulation and of wakefulness and sleep states in the pigeons Columba livia

  2007cites this paper
• News and Reviews The hypothalamic peptidergic system, hypocretin/orexin and vigilance control

  2007cites this paper
• Neuropeptides as possible targets in sleep disorders

  2007cites this paper
• Tachykinins and the control of prolactin secretion.

  2006cites this paper
• Sleep disturbance induced by substance P in mice.

  2006cites this paper
• Peptides and Sleep

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Neuroendocrinology of Sleep

  2006cites this paper
• Protection from neuronal damage evoked by a motivational excitation is a driving force of intentional actions.

  2005cites this paper
• Menopause related sleep disorders.

  2005cites this paper